Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $51,294,396 |
| Sells | 174 | $81,949,239 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 19 Nov 2024 | Sale | 50,000 | 13.9502 | 697,510 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 19 Nov 2024 | Sale | 50,000 | 13.949 | 697,450 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 19 Nov 2024 | Sale | 50,000 | 13.9502 | 697,510 | I |
| 21 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 19 Nov 2024 | Sale | 50,000 | 13.949 | 697,450 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 45,045 | 16.7589 | 754,905 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 4,955 | 17.643 | 87,421 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 45,124 | 16.7604 | 756,296 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Nov 2024 | Sale | 4,876 | 17.6416 | 86,020 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 45,045 | 16.7589 | 754,905 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 4,955 | 17.643 | 87,421 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 45,124 | 16.7604 | 756,296 | I |
| 14 Nov 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Nov 2024 | Sale | 4,876 | 17.6416 | 86,020 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 40,596 | 17.45 | 708,400 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 11 Nov 2024 | Sale | 223,632 | 18.15 | 4,058,921 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,853 | 17.16 | 134,757 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 7,854 | 17.16 | 134,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,554 | 17.77 | 169,775 | I |
| 13 Nov 2024 20:16 | SPRY | ARS Pharmaceuticals Inc | FLYNN JAMES E | 10% | 12 Nov 2024 | Sale | 9,553 | 17.77 | 169,757 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | SCOTT KATHLEEN D. | Chief Financial Officer | 16 Oct 2024 | Sale | 12,500 | 16 | 200,000 | D |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 48,550 | 14.8642 | 721,657 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 1,450 | 15.2539 | 22,118 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Oct 2024 | Sale | 50,000 | 14.8764 | 743,820 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 48,550 | 14.8642 | 721,657 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 1,450 | 15.2539 | 22,118 | I |
| 17 Oct 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Oct 2024 | Sale | 50,000 | 14.8764 | 743,820 | I |
| 10 Oct 2024 16:28 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8277 | 691,385 | I |
| 10 Oct 2024 16:28 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8278 | 691,390 | I |
| 10 Oct 2024 16:27 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8277 | 691,385 | I |
| 10 Oct 2024 16:27 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 08 Oct 2024 | Sale | 50,000 | 13.8278 | 691,390 | I |
| 19 Sep 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 18 Sep 2024 | Sale | 10,000 | 14 | 140,000 | D |
| 19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
| 19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
| 19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
| 19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
| 12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
| 12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
| 12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
| 12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
| 28 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 21 Aug 2024 18:51 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 20 Aug 2024 | Sale | 50,000 | 15 | 750,000 | D |
| 21 Aug 2024 18:51 | SPRY | ARS Pharmaceuticals Inc | KARAS ERIC | Chief Commercial Officer | 19 Aug 2024 | Sale | 10,000 | 14 | 140,000 | D |
| 21 Aug 2024 18:49 | SPRY | ARS Pharmaceuticals Inc | SCOTT KATHLEEN D. | Chief Financial Officer | 20 Aug 2024 | Sale | 12,500 | 16 | 200,000 | D |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 2,261 | 16.2532 | 36,748 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 2,300 | 16.2589 | 37,395 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
| 21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 2,261 | 16.2532 | 36,748 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 2,300 | 16.2589 | 37,395 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
| 21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 13 Aug 2024 | Sale | 30,000 | 13 | 390,000 | D |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 35,363 | 12.7659 | 451,441 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 14,637 | 11.7734 | 172,327 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 35,401 | 12.7646 | 451,880 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 14,599 | 11.7753 | 171,908 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 14,637 | 11.7734 | 172,327 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 35,363 | 12.7659 | 451,441 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 35,401 | 12.7646 | 451,880 | I |
| 15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 14,599 | 11.7753 | 171,908 | I |
| 18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4028 | 570,140 | I |
| 18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4031 | 570,155 | I |
| 18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4031 | 570,155 | I |
| 18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4028 | 570,140 | I |
| 11 Jul 2024 17:04 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6168 | 480,840 | I |
| 11 Jul 2024 17:04 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6177 | 480,885 | I |
| 11 Jul 2024 17:03 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6168 | 480,840 | I |
| 11 Jul 2024 17:03 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6177 | 480,885 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Jun 2024 | Sale | 48,028 | 9.1447 | 439,202 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Jun 2024 | Sale | 47,834 | 9.1454 | 437,461 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 11 Jun 2024 | Sale | 1,972 | 9.0039 | 17,756 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 11 Jun 2024 | Sale | 2,166 | 9.002 | 19,498 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Jun 2024 | Sale | 48,028 | 9.1447 | 439,202 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Jun 2024 | Sale | 47,834 | 9.1454 | 437,461 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 11 Jun 2024 | Sale | 1,972 | 9.0039 | 17,756 | I |
| 13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 11 Jun 2024 | Sale | 2,166 | 9.002 | 19,498 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 May 2024 | Sale | 44,350 | 9.0577 | 401,709 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 May 2024 | Sale | 44,746 | 9.0581 | 405,314 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 May 2024 | Sale | 2,766 | 9.0403 | 25,005 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 May 2024 | Sale | 2,381 | 9.0547 | 21,559 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 14 May 2024 | Sale | 2,884 | 9.0058 | 25,973 | I |
| 16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 14 May 2024 | Sale | 2,873 | 9.0084 | 25,881 | I |
| 16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 May 2024 | Sale | 44,350 | 9.0577 | 401,709 | I |
| 16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 May 2024 | Sale | 44,746 | 9.0581 | 405,314 | I |
| 16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 May 2024 | Sale | 2,381 | 9.0547 | 21,559 | I |
| 16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 May 2024 | Sale | 2,766 | 9.0403 | 25,005 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)